Financial markets

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CLOV, EH, FUBO, IRTC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Thursday, February 25, 2021 - 3:50am

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

Key Points: 
  • If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.
  • KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.
  • KSF serves a variety of clients including public institutional investors, hedge funds, money managers and retail investors in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EBIX, PEN, QS, SWI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Thursday, February 25, 2021 - 3:50am

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

Key Points: 
  • If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.
  • KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.
  • KSF serves a variety of clients including public institutional investors, hedge funds, money managers and retail investors in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.

The Chefs’ Warehouse Announces Pricing of $50 Million of 1.875% Convertible Senior Notes Due 2024

Thursday, February 25, 2021 - 1:59am

The Convertible Notes issuance is a reopening of, and will be part of the same series as, the $150 million aggregate principal amount of 1.875% Convertible Senior Notes due 2024 (the Existing Notes) issued by the Company on November 22, 2019.

Key Points: 
  • The Convertible Notes issuance is a reopening of, and will be part of the same series as, the $150 million aggregate principal amount of 1.875% Convertible Senior Notes due 2024 (the Existing Notes) issued by the Company on November 22, 2019.
  • While the Convertible Notes will initially trade under a Rule 144A CUSIP number, once de-legended, the Convertible Notes will have the same CUSIP number and will be fully fungible with the Existing Notes.
  • The Convertible Notes will be convertible at the option of holders of the Convertible Notes into shares of the Companys common stock, together with cash in lieu of any fractional share.
  • The Convertible Notes will mature on December 1, 2024, unless earlier converted or repurchased in accordance with their terms.

Medigus Announces Proposed Underwritten Public Offering of American Depositary Shares

Thursday, February 25, 2021 - 1:01am

OMER, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (the Company), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it intends to offer its American Depositary Shares (ADSs) for sale in an underwritten public offering.

Key Points: 
  • OMER, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (the Company), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it intends to offer its American Depositary Shares (ADSs) for sale in an underwritten public offering.
  • The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • For example, Medigus uses forward looking statements when describing the proposed offering and the intended use of proceeds from such offering.

Timberland Bancorp, Inc. Announces New Stock Repurchase Program

Thursday, February 25, 2021 - 2:00am

HOQUIAM, Wash., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (NASDAQ: TSBK) (Timberland or the Company), the holding company for Timberland Bank (the Bank) announced today that its Board of Directors has adopted a new stock repurchase program.

Key Points: 
  • HOQUIAM, Wash., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (NASDAQ: TSBK) (Timberland or the Company), the holding company for Timberland Bank (the Bank) announced today that its Board of Directors has adopted a new stock repurchase program.
  • Under the repurchase program, the Company may repurchase up to 5% of the Companys outstanding shares, or 415,970 shares.
  • The new stock repurchase program replaces the existing stock repurchase program, which had 141,952 shares available to be repurchased.
  • The repurchase program does not obligate the Company to purchase any particular number of shares.

theScore Announces Pricing of Upsized Initial Public Offering in the United States

Thursday, February 25, 2021 - 1:00am

Score Media and Gaming Inc. (theScore or the Company) (TSX: SCR) today announced the pricing of its previously-announced marketed public offering of the Companys Class A Subordinate Voting Shares (Class A Shares) in the United States and Canada.

Key Points: 
  • Score Media and Gaming Inc. (theScore or the Company) (TSX: SCR) today announced the pricing of its previously-announced marketed public offering of the Companys Class A Subordinate Voting Shares (Class A Shares) in the United States and Canada.
  • The size of the offering has been increased from the previously announced 5,000,000 Class A Shares.
  • The offering is expected to close on March 1, 2021, subject to customary closing conditions.
  • In connection with the offering, theScore filed a preliminary prospectus supplement to its base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada, other than Qubec.

LEIDOS HOLDINGS ALERT: Bragar Eagel & Squire, P.C. is Investigating Leidos Holdings, Inc. on Behalf of Leidos Stockholders and Encourages Investors to Contact the Firm

Thursday, February 25, 2021 - 1:00am

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Leidos Holdings, Inc. (NYSE: LDOS) on behalf of Leidos stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Leidos Holdings, Inc. (NYSE: LDOS) on behalf of Leidos stockholders.
  • Our investigation concerns whether Leidos has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Leidos stock price fell $3.41 per share, or over 3%, to close at $105.22 per share on February 16, 2021.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against SolarWinds Corporation and Encourages Investors to Contact the Firm

Thursday, February 25, 2021 - 2:00am

Investors have until March 5, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until March 5, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On December 15, 2020, Reuters published an article stating that, last year, security researcher Vinoth Kumar alerted the company that anyone could access SolarWinds update server by using the password solarwinds123.
  • On this news, the Companys shares fell $1.56 per share or 8% to close at $18.06 per share on December 15, 2020.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

LMP Announces $20 Million Private Placement of Series A Convertible Preferred Stock

Thursday, February 25, 2021 - 12:25am

LMP will issue and sell 20,100 shares of a newly created series of Series A Convertible Preferred Stock (the Preferred Stock) in a privately negotiated transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the Securities Act), and the rules and regulations promulgated thereunder.

Key Points: 
  • LMP will issue and sell 20,100 shares of a newly created series of Series A Convertible Preferred Stock (the Preferred Stock) in a privately negotiated transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the Securities Act), and the rules and regulations promulgated thereunder.
  • The Preferred Stock will be convertible into shares of LMPs common stock at an initial conversion price of $17.50 per share.
  • The Investors will also receive warrants (the Warrants) to purchase 861,429 shares of LMPs common stock at an exercise price of $21.00 per share.
  • You are cautioned not to place undue reliance on forward-looking statements, which reflect expectations only as of this date.

ESMA publishes second Annual Report on waivers and deferrals for non-equity instruments

Thursday, February 25, 2021 - 12:08am

24 February 2021

Key Points: 
  • 24 February 2021

    MiFID - Secondary Markets

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today published its second Annual Report on waivers and deferrals for non-equity instruments under MiFIR.

  • This report includes an analysis of the waivers for non-equity instruments for which ESMA issued an opinion to the NCAs in the period between 1 January and 31 December 2019.
  • It also includes an overview of the deferral regime for non-equity instruments applied across the different Member States.
  • As part of this mandate it submits an annual report to the European Commission on how equity and non-equity waivers and deferrals regimes are applied in practice.